大量资金正在借道公募基金入市。2月11日，33只新基金集中发布基金合同生效公告，发行规模合计超过300亿元；而年内新基金发行规模已超 过1800亿元，较去年同期翻倍。从新基金类型来看，时隔3年多，新发主动权益类爆款基金再度批量出现。 爆款权益类基金批量涌现 新基金加速成立。2月11日，33只新基金集中发布基金合同生效公告，发行规模合计达到309.89亿元。其中，权益类基金成为主力军，发行规 模合计为204.24亿元。 拉长期限来看，截至2月11日，今年以来已有199只新基金成立，发行规模为1858.64亿元。对比之下，去年同期共成立了117只基金，发行规模 为859.91亿元。 从年内新基金发行情况来看，权益类基金频现爆款，尤其是主动权益类基金热度显著提升。具体来看，广发研究智选混合基金发行规模为 72.21亿元，华宝优势产业混合基金发行规模为57.77亿元，广发中证500指数量化增强基金发行规模为56.05亿元，银华智享混合基金发行规模 为50.99亿元。 以下是年内发行规模超20亿元的权益类基金： | 基金简称 | 发行规模 (亿元) | | --- | --- | | 广发研究智选混合 | 72.21 ...

Core Viewpoint - 华夏基金 maintains its leading position in the ETF market, approaching a scale of 1 trillion, but faces significant challenges with a sharp decline in the scale of actively managed equity funds, leading to multiple products nearing liquidation [1][13]. Group 1: ETF Business Performance - As of the end of 2025, 华夏基金's ETF (non-monetary) management scale reached 956.9 billion, ranking first in the market, although its market share decreased by 2.09% compared to 2024 [2][19]. - The gap between 华夏基金 and the second-ranked 易方达基金 expanded from 56.3 billion at the end of 2024 to 79.3 billion by the end of 2025, indicating an increasing competitive advantage [2][14]. - On January 12, 2026, 华夏基金's ETF management scale briefly exceeded 1 trillion, reaching 1,016.7 billion, but by February 6, it had shrunk to approximately 750 billion, a decline of over 25% [10][20]. Group 2: Active Equity Fund Challenges - The scale of 华夏基金's actively managed equity funds has significantly decreased, with stock fund assets dropping from 43.4 billion at the end of 2021 to 24.4 billion by the end of 2025, a reduction of nearly 20 billion [11][21]. - The scale of mixed funds also fell from 210.1 billion to 128.4 billion during the same period, resulting in a total decline of over 100 billion across actively managed equity funds [11][21]. - The persistent shrinkage has led to a proliferation of "mini funds," with several products, including 华夏红利量化选股股票 and 华夏新锦升混合, falling below the 50 million liquidation threshold [12][23]. Group 3: Fund Launches and Liquidations - As of February 6, 2026, 81 out of 282 newly launched funds in the year had announced early termination of fundraising, including 华夏基金's 华夏经典回报混合 [3][15]. - Two ETF linked funds, 华夏中证沪港深500ETF and 华夏中证新能源ETF, were liquidated due to asset sizes falling below 200 million, triggering automatic termination clauses [6][18]. - The 华夏新材料龙头混合发起式 fund is particularly at risk, having issued a notice regarding potential contract termination if its net asset value remains below 200 million by February 24, 2026 [12][24].

Group 1 - The public fund issuance market has been heating up since the beginning of the year, with the first active equity fund exceeding 7 billion yuan in fundraising, specifically the Guangfa Research Smart Mixed Fund at 7.221 billion yuan [1] - Other active equity funds have also seen significant fundraising, including the E Fund Balanced Selection Mixed Fund at 3.408 billion yuan, the Huitianfu Technology Leading Mixed Fund at 2.704 billion yuan, and the Yongying Value Core Mixed Fund at 1.672 billion yuan [1] - Due to the influx of funds, some high-performing funds have started to tighten subscription limits, with specific funds reducing daily subscription limits from 500,000 yuan to as low as 10,000 yuan [1] Group 2 - Industry insiders believe that the recovery of active equity fund performance will lead to expected incremental capital in the future, as the long-term trend of changing household asset allocation is still in its early stages [2] - According to the latest public fund quarterly report, several high-performing funds saw significant growth in scale, with the Yongying Pioneer Semiconductor Smart Mixed Fund increasing from 403 million yuan to 9.326 billion yuan, and the Yongying High-end Equipment Smart Mixed Fund growing from 1.135 billion yuan to 9.765 billion yuan by the end of 2025 [3] - The substantial growth in fund scale is attributed to both rising net values and continuous inflows of capital, with notable increases seen in funds focusing on niche industries and those employing balanced allocation strategies with strong long-term performance [3]

Core Insights - The A-share market has shown an upward trend since 2025, leading to a general recovery in the performance of actively managed equity funds, with the total industry scale approaching a new high of 36 trillion [1][13] - Among 4,711 actively managed equity funds with performance records, 4,494 reported positive returns over the past year, while 217 had negative returns [1][13] - The top 30 funds with the largest declines all had annual returns below -9.75%, with several funds losing over 15%, including Huafu Medical Innovation A at -27.13% [1][14] Fund Performance - The worst-performing funds include: - Huafu Medical Innovation A: -27.13% return, size 0.60 billion [2][14] -浦银安盛医疗创新A: -20.29% return, size 0.16 billion [2][14] - 鑫元消费甄选A: -19.65% return, size 0.29 billion [2][14] - The performance of the top 30 funds with the largest declines indicates significant underperformance, with many funds experiencing substantial losses [1][15] Historical Performance Analysis - Dongwu Industry Rotation A and Dongwu Progress Strategy A, managed by Zhao Meiling, have shown poor performance, with returns of -12.66% and -10.90% respectively [3][15] - Both funds have long histories, with Dongwu Industry Rotation A established in April 2008 and Dongwu Progress Strategy A in May 2009, yet they have consistently underperformed in recent years [4][16] - The three-year returns for these funds are -22.25% and -24.34%, significantly lagging behind their benchmarks [4][16] Portfolio Composition - The two funds exhibit high similarity in their holdings, with overlapping top ten stocks that have generally performed poorly recently [5][17] - Key holdings for Dongwu Industry Rotation A include: - 分众传媒: 8.52% - 恒瑞医药: 6.94% - 圆通速递: 6.71% [19] - Recent performance of these stocks has been detrimental to the funds' net values, with significant declines observed [19] Industry Trends - Zhao Meiling's funds have a long-term focus on consumer, pharmaceutical, and high-end manufacturing sectors, which have shown mixed performance in recent structural market conditions [12][24] - The overall market for actively managed equity funds in 2025 has been positive, but significant internal differentiation exists, with some thematic products and smaller funds struggling amid market volatility [12][24]

Core Insights - The A-share market has shown an upward trend since 2025, leading to a general recovery in the performance of actively managed equity funds, with the total industry scale approaching a new high of 36 trillion yuan [1][14] - Among 4,711 actively managed equity funds with performance records, 4,494 reported positive returns, while 217 had negative returns over the past year [1][14] - Notably, the worst-performing funds had annual returns below -9.75%, with several losing over 15%, including Huafu Medical Innovation A at -27.13% [1][14] Fund Performance - The top three worst-performing funds included: - Huafu Medical Innovation A: -27.13% return, 0.60 billion yuan in size [2][15] -浦银安盛医疗创新A: -20.29% return, 0.16 billion yuan in size [2][15] - 鑫元消费甄选A: -19.65% return, 0.29 billion yuan in size [2][15] - Among the top 30 funds with the largest declines, six were managed by GF Fund under manager Wang Mingxu [1][14] Manager Performance - Wang Mingxu's managed funds have shown a significant decline in scale, dropping from a peak of 30.65 billion yuan in Q2 2021 to 8.26 billion yuan by Q4 2025, with six of his eight funds in the top 30 worst performers [4][17] - The funds managed by Wang exhibit a high degree of similarity in their holdings, leading to collective underperformance [10][23] Investment Strategy - Wang's flagship fund, GF Domestic Demand Growth A, experienced a significant style shift in 2025 but failed to improve performance, ending the year with a -16.31% return [5][18] - The fund's portfolio included heavyweights in the liquor, real estate, banking, and brokerage sectors, but the performance of these stocks was weak, with many declining over 10% [21][23] - Despite attempts to diversify into technology and manufacturing stocks, the overall results remained disappointing, indicating a mismatch between investment strategy and market conditions [13][23]

Core Insights - The A-share market has shown an upward trend since 2025, leading to a general recovery in the performance of actively managed equity funds, with the total industry scale approaching 36 trillion yuan [1][10] - Among 4,711 actively managed equity funds with performance records, 4,494 reported positive returns, while 217 had negative returns over the past year [1][10] - Over a three-year period, 924 out of 3,792 funds recorded negative returns, indicating a significant number of funds struggling to maintain performance [1][10] - The top 30 funds with the worst annual returns all had returns below -9.75%, with several funds losing over 15% [1][10] Fund Performance - The worst-performing fund, Huafu Medical Innovation A, had a return of -27.13%, followed by浦银安盛医疗创新A at -20.29% and 鑫元消费甄选A at -19.65% [2][11] - The performance of the top 30 funds with the largest declines highlights the challenges faced by certain actively managed funds in a fluctuating market [12][18] Specific Fund Analysis - 鑫元消费甄选A, managed by 姚启瑶, has shown particularly poor performance with a return of -19.85% since its inception in March 2023, resulting in a cumulative return of -49.37% [12][18] - The fund has experienced three changes in fund managers within a short period, which has led to challenges in maintaining a consistent investment strategy [13][18] - The current fund manager, 姚启璠, has a return of -2.41% since taking over in July 2025, with a focus on media and consumer sectors, but has faced challenges due to poor performance of key holdings [15][18] Market Trends - The overall market for actively managed equity funds has shown positive trends, but significant internal differentiation exists, with some thematic funds and smaller-scale funds struggling amid market volatility [18] - The ability to enhance flexibility in asset allocation and improve stock selection accuracy will be crucial for these funds to recover from their current low performance [18]

Core Insights - The article discusses the challenge of achieving both performance and scale growth for large-cap active equity funds in the context of a rising equity market over the past year [1] Group 1: Performance of Large-Cap Active Equity Funds - As of the third quarter, there are 33 active equity funds with assets exceeding 10 billion yuan, with E Fund Blue Chip Select leading at 36.413 billion yuan [2] - Most of these funds have achieved positive returns over the past year, with notable performances such as Yongying Technology Smart Mixed Fund returning approximately 270% [2] - Other funds like China Europe Digital Economy Mixed Fund and Yongying Advanced Manufacturing Smart Mixed Fund also reported returns of 181.08% and 136.49% respectively [2] Group 2: Scale Changes and Market Dynamics - Despite strong performance, over half of the large-cap active equity funds have experienced a decline in scale, with 10 funds seeing reductions of over 20% [4] - The difficulty in adjusting positions for larger funds and the growing preference for ETFs among investors have contributed to this trend [4] - A fund manager noted that sustained long-term performance is crucial for retaining investors [4] Group 3: Future Strategies and Market Outlook - Fund managers are focusing on sectors like domestic consumption, technology, and high-end manufacturing for the fourth quarter [5][6] - E Fund Blue Chip Select's manager emphasizes the importance of free cash flow and intrinsic value accumulation in driving market capitalization growth [5] - The manager of Xinchuan He Run Fund highlights the positive interaction between fundamentals and liquidity, suggesting a potential market trend reversal [6]

Core Insights - The announcement of the retirement of He Yanping, the former General Manager of Western Gain Fund, and the appointment of He Fang as the acting General Manager highlights a significant leadership change within the company [2] - Under He Yanping's management from November 2015 to September 2025, the fund's management scale increased dramatically from 9.3 billion to 116.6 billion, marking a growth of over 100 billion [2] - The current product structure of Western Gain Fund is heavily weighted towards bond and money market funds, which together account for the majority of the management scale, while equity and mixed funds remain relatively small [2] Company Overview - He Yanping's career prior to joining Western Gain Fund included roles at various securities and fund companies, indicating a strong background in the financial industry [2] - The largest actively managed equity fund at Western Gain Fund, the Western Gain CSI 500 Index Enhanced Fund, has a size of only 1.79 billion, suggesting that the company has a limited presence in the active equity fund market [3] - The company currently manages only two ETF products with a combined size of 0.868 billion, indicating a need for diversification in its product offerings [3]

Group 1 - Multiple actively managed equity funds announced purchase limits on September 6, with adjustments effective from September 8, including limits of 500,000, 100,000, and 50,000 yuan for various funds [1][2] - As of September 5, 98.24% of 7,792 actively managed equity funds reported positive returns year-to-date, with the A-share indices rising by 13.75%, 20.89%, and 38.13% respectively [3] - The recent surge in the market has led to concentrated purchase limits, with fund managers aiming to maintain investment styles and protect existing investors' interests [2][3] Group 2 - The "champion fund" of the year, Yongying Technology Select Mixed Fund, reduced its large purchase limit to 10,000 yuan on September 5, after previously adjusting it to 1 million yuan on August 27 [3] - Fund managers are implementing purchase limits to prevent rapid growth in fund size and encourage rational investment behavior among investors [3]

Group 1 - The total profit of public funds reached 636.17 billion yuan in the first half of 2025, indicating a significant increase in fund performance compared to the previous year [1][2] - The number of public fund managers reporting profits is high, with 155 out of 162 showing positive results, led by E Fund with a profit of 58.40 billion yuan [2] - The total management scale of public funds reached 34.39 trillion yuan by the end of June 2025, surpassing 35 trillion yuan by the end of July, reflecting a growing market [3] Group 2 - The top three sectors by market value held by public funds are Electronics (16.41%), Pharmaceuticals (9.79%), and Power Equipment (8.23%) [3] - The issuance of active equity funds has increased significantly, with a total issuance of 85.96 billion yuan in 2025, up nearly 60% from the previous year [3] - The trend of "daylight funds" has emerged, indicating strong demand and market activity, as seen with the rapid fundraising of the招商均衡优选混合 fund [3][4]